Is Medpace Holdings, Inc. overvalued?

Medpace Holdings, Inc. (MEDP) looks overvalued — trading about 19% above its fair value.

Overvalued

Price

$653.94

Fair value

$529.78

Current P/E

41.1

Normal P/E

33.3

Market cap

$18.29B

Dividend yield

0.0%

Return on equity

99.8%

Sector

Healthcare

Fair value compares MEDP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks